Targeting HIF-1 for Prostate Cancer: A Synthesis of Preclinical Evidence

By
Bob
-
0
77
Scientists focus on the potential of targeting hypoxia-inducible factor (HIF) in prostate cancer (PC) and summarize the scientific background of HIF activity in PC.
[Expert Opinion on Therapeutic Targets]
Abstract